Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 2 Neoplasms 2 Esophageal Neoplasms 2 Stomach Neoplasms 1 Liver Neoplasms 1 Liver Cirrhosis 1 Fibrosis 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Barrett Esophagus 1 Adenocarcinoma Of Esophagus 1

Interventions

Fulvestrant 125 Trastuzumab 114 Paclitaxel 113 Letrozole 108 pembrolizumab 79 pertuzumab 75 palbociclib 75 Capecitabine 72 Anastrozole 72 Cyclophosphamide 70 Carboplatin 67 abemaciclib 64 exemestane 63 Tamoxifen 63 ribociclib 60 trastuzumab deruxtecan 57 Surveys and Questionnaires 51 Specimen Handling 50 Radiotherapy 49 Docetaxel 49 Magnetic Resonance Spectroscopy 48 Blood Specimen Collection 40 olaparib 39 Standard of Care 36 Biopsy 33 sacituzumab govitecan 31 130-nm albumin-bound paclitaxel 31 Doxorubicin 30 Exercise 29 eribulin 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Breath Tests × 1 year × Clear all

NCT07038785 2026-05-15

PINK

SpotitEarly

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡